Search

Search Constraints

You searched for: Author/Creator Allmer, Cristine

Search Results

1. A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B‐cell non‐Hodgkin lymphoma. Issue 7 (12th June 2013)

2. A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts. (9th September 2016)

3. Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era. Issue 8 (27th May 2021)

4. Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study. (18th August 2017)

5. Early event status informs subsequent outcome in newly diagnosed follicular lymphoma. Issue 11 (3rd September 2016)

6. Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein‐10 predicts inferior prognosis in untreated diffuse large B‐cell lymphoma. Issue 4 (10th February 2014)

7. Elevated soluble IL‐2Rα, IL‐8, and MIP‐1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma. Issue 12 (19th September 2014)

8. FCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein–Barr virus status. Issue 11 (November 2013)

9. Human Pegivirus infection and lymphoma risk and prognosis: a North American study. (29th May 2018)

10. Impact of metformin use on the outcomes of newly diagnosed diffuse large B‐cell lymphoma and follicular lymphoma. (28th May 2019)